Glenn Baity, VP AND GC at ACADIA PHARMACEUTICALS INC (ACAD), sold 50,000 shares at $12.30 ($619K) on 2013-04-16, disclosed to the SEC on 2013-04-17.
Scheduled sale ($619k) by VP AND GC under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.50 | 20,000 | $250K | 40.4% |
| 2 | $12.30 | 20,000 | $246K | 39.8% |
| 3 | $12.26 | 10,000 | $123K | 19.8% |
| Total | $12.37 avg | 50,000 | $619K | 100% |
| Filing → |
| ACAD | SELL | 2017-10-06 | $3.1M | — | Filing → |
| ACAD | SELL | 2017-09-01 | $924K | — | Filing → |
| ACAD | SELL | 2017-08-11 | $500K | — | Filing → |